Ipigrix solution for injections 5mg/ml, 1ml x 10 ampoules — Made in Latvia — Free Delivery

From the reproductive system: increased tone of the uterus.

In case of development of undesirable side effects, reduce the dose or briefly (for 1-2 days) interrupt the use of the preparation. Salivation and a decrease in heart rate can be reduced with M-anticholinergics (atropine, etc.).

The course of ba, epilepsy, thyrotoxicosis, gastric and duodenal ulcers may become aggravated. care should also be taken in diseases of the cardiovascular system.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. During the period of treatment, it is necessary to refrain from driving vehicles, as well as from engaging in potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.

Use during pregnancy or lactation. The preparation increases the tone of the uterus and can cause premature birth, so during pregnancy, the use of the preparation is contraindicated.

The use of the preparation during lactation is contraindicated.

Children. Due to the lack of data on the safety of the preparation in children, it is not prescribed to patients of this age group.

Ipigrix enhances the sedative effect in combination with CNS depressants. action and side effects are enhanced when used in combination with other cholinesterase inhibitors and m-cholinomimetic agents. in patients with myasthenia gravis, the risk of developing a "cholinergic" crisis increases if ipigrix is ​​used simultaneously with cholinergic agents. the risk of developing bradycardia increases if β-adrenergic blockers were used before the start of treatment with the preparation.

Ipigrix can be used in combination with nootropic preparations.

Alcohol enhances the side effects of the preparation.

Symptoms: bronchospasm, increased sweating, pupillary constriction, nystagmus, increased gastrointestinal motility, spontaneous defecation and urination, vomiting, jaundice, bradycardia, intracardiac conduction disturbances, arrhythmia, arterial hypotension, anxiety, anxiety, agitation, fear, ataxia, convulsions, coma , speech disorder, drowsiness, general weakness.

Treatment: symptomatic therapy is used, M-anticholinergics: atropine, cyclodol, metacin, etc.

At a temperature not higher than 25 ° C. do not freeze!